Nabil El Asraoui

Nabil El Asraoui is an Associate Director at BDC Venture Capital, a position he has held since 2022 after earning his Master of Business Administration from McGill University in 2016. He currently specializes in private market fund investments across venture capital, private equity, and private debt, focusing primarily on innovative Canadian technology companies. His recent investment portfolio includes participation in significant funding rounds, notably co-investing in a $750 million Series C financing for Waabi in January 2026. He has also been involved in other major transactions, including co-investing in a $39.5 million round for Congruence Therapeutics in March 2026 and backing a $10 million Series A for Cybrid. Additionally, El Asraoui led a $4.1 million Seed round for Enurgen in October 2025, highlighting his ongoing commitment to deploying capital to scale emerging enterprises across the Canadian technology sector.